Evaluation of a Smartphone Application for Self-help for Social Anxiety
SMASH
1 other identifier
interventional
165
1 country
2
Brief Summary
The present study examines whether a self-help app can reduce symptoms of social anxiety disorder.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2022
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 12, 2022
CompletedFirst Posted
Study publicly available on registry
September 26, 2022
CompletedStudy Start
First participant enrolled
October 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2023
CompletedSeptember 26, 2022
September 1, 2022
1 year
September 12, 2022
September 16, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Change in SAD-related symptom severity measured by the Liebowitz Social Anxiety Scale
The LSAS is a clinician-rated interview designed to measure fear and avoidance in different social situations. The situations are rated on scale from 0 ("not at all" or "never") to 3 (severe" or "most of the time"), with higher scores indicating greater symptoms of social anxiety.
change from baseline (week 0) to week 12 (post) and to week 36 (follow-up)
Secondary Outcomes (16)
Change in SAD-related symptoms measured by the Social Phobia Inventory (SPIN)
change from baseline to week 12 (post) and to week 36 (follow-up)
Change in the Social Phobic Cognition Questionnaire (SPK)
change from baseline to week 12 (post) and to week 36 (follow-up)
Pain and Disability Index (PDI)
change from baseline to week 12 (post) and to week 36 (follow-up)
Beck Depression Inventory - Fast Screen (BDI-FS)
change from baseline to week 12 (post) and to week 36 (follow-up)
World Health Organization Quality of Life (WHO-QOL-BREF)
change from baseline to week 12 (post) and to week 36 (follow-up)
- +11 more secondary outcomes
Study Arms (3)
App condition
EXPERIMENTALAll participants will receive access to the developed social anxiety disorder (SAD) treatment app for 12 weeks.
App with accompanying therapy sessions
EXPERIMENTALIn addition to being able to use the app to treat social anxiety over a 12-week period, participants will receive a total of 8 video therapy sessions based on cognitive behavioral therapy to accompany their use of the app.
Waitlist control condition
NO INTERVENTIONDelayed use of the mobile application after 12 weeks.
Interventions
The app provides a 12-week adaptation of scientifically proven cognitive behavioral therapy techniques for the treatment of SAD and is intended for use as a mobile intervention. The app includes modules such as learning (e.g., creating a model, learning about the maintaining factors), changing the maintaining factors (e.g., safety behaviors), or behavioral experiments.
In addition to using the app, patients receive a total of 8 video-based therapy sessions over the course of 12 weeks. The sessions include topics such as video feedback and behavioral experiments.
Eligibility Criteria
You may qualify if:
- Current diagnosis of Social Anxiety Disorder
- Written informed consent before the start of the study
- Age: 18 to 65 years
- Possession of smartphone
- Familiarity with using smartphone apps
You may not qualify if:
- Acute suicidality
- Active substance abuse or dependence
- Severe medical conditions (e.g., chronic cardiovascular disease)
- Severe depression
- Psychotic disorder
- Bipolar disorder
- Borderline personality disorder
- Current psychotherapeutic treatment
- Current psychopharmacological treatment
- No proficient skills in the German language
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Goethe Universitylead
- Technische Universität Dresdencollaborator
- Mindable Health GmbHcollaborator
Study Sites (2)
Technische Universitaet Dresden
Dresden, 01187, Germany
Goethe Universitaet Frankfurt
Frankfurt, 60486, Germany
Study Officials
- PRINCIPAL INVESTIGATOR
Ulrich Stangier, Professor
Goethe University Frankfurt
- PRINCIPAL INVESTIGATOR
Jürgen Hoyer, Professor
Technische Universitaet Dresden
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Outcome assessors are blinded to the conditions, but blinding of participant and care provider is not possible due to the nature of the intervention.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 12, 2022
First Posted
September 26, 2022
Study Start
October 1, 2022
Primary Completion
October 1, 2023
Study Completion
October 1, 2023
Last Updated
September 26, 2022
Record last verified: 2022-09
Data Sharing
- IPD Sharing
- Will share
The data used in this study is available from the corresponding authors upon reasonable request.